Protein kinase Cδ in tumorigenesis of human malignant fibrous histiocytoma

Oncology Reports

Volumn 26, Issue 5, 2011, Pages 1221-1226

  Fukase, Naomasa ^a   Kawamoto, Teruya ^a   Kishimoto, Kenta ^a   Hara, Hitomi ^a   Okada, Yoshiyuki ^a   Onishi, Yasuo ^a   Toda, Mitsunori ^a   Kurosaka, Masahiro ^a   Akisue, Toshihiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Malignant fibrous histiocytoma; Protein kinase C ; Tumorigenesis

Indexed keywords

MESSENGER RNA; PROTEIN KINASE C DELTA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALIGNANT FIBROUS HISTIOCYTOMA; MUSCULOSKELETAL DISEASE; NEURILEMOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN KINASE C DELTA GENE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GENE; TUMOR VASCULARIZATION;

APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; PROTEIN KINASE C-DELTA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 80053139310     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1415     Document Type: Article

References (39)

1. Papai Z, Bodoky G, Szanto J, et al: The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma. Cancer 89: 177-180, 2000.
2. Spira AI and Ettinger DS: The use of chemotherapy in soft-tissue sarcomas. Oncologist 7: 348-359, 2002.
3. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698, 1984.
4. Griner EM and Kazanietz MG: Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7: 281-294, 2007.
5. Fishman DD, Segal S and Livneh E: The role of protein kinase C in G1 and G2/M phases of the cell cycle (Review). Int J Oncol 12: 181-186, 1998.
6. Dempsey EC, Newton AC, Mochly-Rosen D, et al: Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279: L429-L438, 2000.
7. Haughian JM, Jackson TA, Koterwas DM and Bradford AP: Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta. Endocr Relat Cancer 13: 1251-1267, 2006.
8. Fischer JW: Protein kinase C delta: a master regulator of apoptosis in neointimal thickening? Cardiovasc Res 85: 407-408, 2010.
9. Koivunen J, Aaltonen V and Peltonen J: Protein kinase C (PKC) family in cancer progression. Cancer Lett 235: 1-10, 2006.
10. D'Costa AM, Robinson JK, Maududi T, Chaturvedi V, Nickoloff BJ and Denning MF: The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas. Oncogene 25: 378-386, 2006.
11. Reno EM, Haughian JM, Dimitrova IK, Jackson TA, Shroyer KR and Bradford AP: Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors. Hum Pathol 39: 21-29, 2008.
12. Evans JD, Cornford PA, Dodson A, Neoptolemos JP and Foster CS: Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer. Am J Clin Pathol 119: 392-402, 2003.
13. Tsai JH, Hsieh YS, Kuo SJ, et al: Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma. Cancer Lett 161: 171-175, 2000.
14. Jackson DN and Foster DA: The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. FASEB J 18: 627-636, 2004.
15. Kiyozuka Y, Nakagawa H, Uemura Y, et al: Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus. Cancer Genet Cytogenet 127: 7-15, 2001.
16. Nakatani T, Marui T, Yamamoto T, Kurosaka M, Akisue T and Matsumoto K: Establishment and characterization of cell line TNMY1 derived from human malignant fibrous histiocytoma. Pathol Int 51: 595-602, 2001.
17. Liang CC, Park AY and Guan JL: In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333, 2007.
18. Masur K, Lang K, Niggemann B, Zanker KS and Entschladen F: High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells. Mol Biol Cell 12: 1973-1982, 2001.
19. Wetsel WC, Khan WA, Merchenthaler I, et al: Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 117: 121-133, 1992.
20. Podar K, Tai YT, Lin BK, et al: Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation. J Biol Chem 277: 7875-7881, 2002.
21. Jiang XH, Tu SP, Cui JT, et al: Antisense targeting protein kinase C alpha and beta1 inhibits gastric carcinogenesis. Cancer Res 64: 5787-5794, 2004.
22. Mandil R, Ashkenazi E, Blass M, et al: Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res 61: 4612-4619, 2001.
23. Leirdal M and Sioud M: Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells. Br J Cancer 80: 1558-1564, 1999.
24. Schwartz GK, Jiang J, Kelsen D and Albino AP: Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst 85: 402-407, 1993.
25. Zhang J, Anastasiadis PZ, Liu Y, Thompson EA and Fields AP: Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway. J Biol Chem 279: 22118-22123, 2004.
26. Yoshiji H, Kuriyama S, Ways DK, et al: Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer Res 59: 4413-4418, 1999.
27. Xia P, Aiello LP, Ishii H, et al: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98: 2018-2026, 1996.
28. Hanania N, Lezenes JR and Castagna M: Tumorigenicity-associated expression of protein kinase C isoforms in rhabdomyosarcoma-derived cells. FEBS Lett 303: 15-18, 1992.
29. Geng WD, Boskovic G, Fultz ME, et al: Regulation of expression and activity of four PKC isozymes in confluent and mechanically stimulated UMR-108 osteoblastic cells. J Cell Physiol 189: 216-228, 2001.
30. Keller HU, Hunziker IP, Sordat B, Niggli V and Sroka J: Protein kinase C isoforms involved in regulation of cell shape and locomotion of human fibrosarcoma HT1080 cells. Int J Cancer 88: 195-203, 2000.
31. Zhan M, Yu D, Liu J, Glazer RI, Hannay J and Pollock RE: Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation. J Biol Chem 280: 4825-4833, 2005.
32. Kawamoto T, Akisue T, Kishimoto K, et al: Inhibition of PKCalpha activation in human bone and soft tissue sarcoma cells by the selective PKC inhibitor PKC412. Anticancer Res 28: 825-832, 2008.
33. Yadav V, Yanez NC, Fenton SE and Denning MF: Loss of protein kinase C delta gene expression in human squamous cell carcinomas: a laser capture microdissection study. Am J Pathol 176: 1091-1096, 2010.
34. Fukumoto S, Nishizawa Y, Hosoi M, et al: Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J Biol Chem 272: 13816-13822, 1997.
35. Vucenik I, Ramakrishna G, Tantivejkul K, Anderson LM and Ramljak D: Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation. Breast Cancer Res Treat 91: 35-45, 2005.
36. Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK and Kazanietz MG: Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem 280: 33926-33934, 2005.
37. Datta K, Nambudripad R, Pal S, Zhou M, Cohen HT and Mukhopadhyay D: Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer. J Biol Chem 275: 20700-20706, 2000.
38. Kiley SC, Clark KJ, Goodnough M, Welch DR and Jaken S: Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res 59: 3230-3238, 1999.
39. Kiley SC, Clark KJ, Duddy SK, Welch DR and Jaken S: Increased protein kinase C delta in mammary tumor cells: relationship to transformtion and metastatic progression. Oncogene 18: 6748-6757, 1999.